Abstract
Handgrip strength is a crucial indicator to monitor the change of cognitive function over time, but its mechanism still needs to be further explored. We sampled 59 monozygotic twin pairs to explore the potential mediating effect of DNA methylation (DNAm) on the association between handgrip strength and cognitive function. The initial step was the implementation of an epigenome-wide association analysis (EWAS) in the study participants, with the aim of identifying DNAm variations that are associated with handgrip strength. Following that, we conducted an assessment of the mediated effect of DNAm by the use of mediation analysis. In order to do an ontology enrichment study for CpGs, the GREAT program was used. There was a significant positive association between handgrip strength and cognitive function (β = 0.194, P < 0.001). The association between handgrip strength and DNAm of 124 CpGs was found to be statistically significant at a significance level of P < 1 × 10−4. Fifteen differentially methylated regions (DMRs) related to handgrip strength were found in genes such as SNTG2, KLB, CDH11, and PANX2. Of the 124 CpGs, 4 within KRBA1, and TRAK1 mediated the association between handgrip strength and cognitive function: each 1 kg increase in handgrip strength was associated with a potential decrease of 0.050 points in cognitive function scores, mediated by modifications in DNAm. The parallel mediating effect of these 4 CpGs was −0.081. The presence of DNAm variation associated with handgrip strength may play a mediated role in the association between handgrip strength and cognitive function.
Similar content being viewed by others
Introduction
Cognitive decline, which significantly impacts daily functioning and independence, is prevalent during the aging process [1]. It arises as a result of age-related neurodegenerative processes and can potentially progress to dementia [2]. With the advent of population aging, the incidence rates of mild cognitive impairment (MCI) and dementia are steadily increasing [3]. This poses substantial challenges for healthcare systems, society, and families alike. Cognitive decline is influenced by intricate interplays among environmental, disease-related, and genetic factors, potentially mediated by epigenetic modifications. Despite considerable advances in the field of genetics [4,5,6,7], the specific pathogenesis underlying cognitive decline remains to be fully elucidated.
Handgrip strength, as a crucial indicator for monitoring changes in cognitive function over time [8], has been widely utilized due to its non-invasive, convenient, and well-received attributes [9, 10]. A recent study has indicated that weaker handgrip strength was a significant risk factor for a late-life-dementia events in community-dwelling older women [11]. Several population-based prospective cohort studies have found that lower handgrip strength was associated with cognitive decline, regardless of gender, in both males and females [12,13,14]. Furthermore, recent literature reviews have robustly confirmed the association between handgrip strength and cognitive decline [8, 15]. Handgrip strength has the potential to influence cognitive function by affecting oxidative stress and inflammatory pathways [16]. Moreover, the association between handgrip strength and cognitive function might stem from common pathologies associated with hormone levels and inflammatory biomarkers [17]. As a result, handgrip strength might be associated with cognitive decline through these or related processes.
In contemporary research, there is an extensive exploration of the involvement of epigenetic modifications, particularly DNA methylation (DNAm) variations, in the underlying mechanisms of complex traits and diseases. Ivana Alece Arantes Moreno et al. discovered that the DNAm level of BDNF promoters was associated with episodic memory deficits [18]. Di Francesco et al. observed a general elevation in DNAm levels in peripheral blood mononuclear cells from individuals with late-onset Alzheimer’s disease, and this increase was found to be associated with inferior cognitive function [19]. In recent years, the association between epigenetic modifications and handgrip strength has garnered attention from researchers. Mark D. Peterson et al. demonstrated that handgrip strength is inversely associated with DNAm age acceleration [20]. However, there has been no research exploring whether DNAm variations associated with handgrip strength mediate the relationship between handgrip strength and cognitive function.
Nowadays, the discordant monozygotic twin design has gained significant prominence as a robust and widely employed methodology in epigenome-wide association studies (EWASs) [21, 22], facilitating the control of individual genetic factors and enabling comprehensive investigations into the epigenetic landscape. In this study, we utilized a group of monozygotic twins to examine the possible mediating role of DNAm in the association between handgrip strength and cognitive function using a combination of causal inference testing and mediation analysis.
Materials and methods
Participants
We conducted the present study using data from the Qingdao Twins Registry System. A detailed description of participant recruitment and data collection has been provided previously [23]. Participants who were pregnant or lactating females, those with major diseases, those who were unable to finish the assessment, professional athletes, and monozygotic twins were excluded from the study. Finally, a total of 59 pairs of monozygotic twins were included in this study. Prior to completing the survey questionnaire and health examination, all participants were required to fast for 10–12 h. Blood samples were collected post-fasting. The separated serum and plasma were immediately frozen at −80°C within 30 min to maintain their integrity. The Regional Ethics Committee of the Qingdao Centers for Disease Control and Prevention (CDC) Institutional Review Boards approved this study, and we followed the ethical principles of the Helsinki Declaration. In addition, we obtained prior written informed consent from all participants.
Measurement of handgrip strength
Trained investigators conducted physical examinations, which involved measuring handgrip strength using Nantong-manufactured WCS-100 handgrip dynamometers. Participants were instructed to apply maximum force while squeezing the handle. For each hand, three measurements were made, and the highest value was chosen for analysis.
Measurement of cognitive function
The Montreal Cognitive Assessment (MoCA, Chinese version), a highly reliable and widely accepted tool [24, 25], was used to measure cognitive function in Chinese adults. The MoCA test evaluates multiple cognitive domains, such as attention, naming, delayed recall, language, visuospatial/executive abilities, orientation, and abstraction, and yields a maximum total score of 30 points. To account for the influence of education on cognitive performance, education-adjusted scores were used [26]. A reduction in cognitive scores is indicative of a decline in cognitive capacity.
Reduced representation bisulfite sequencing (RRBS) analysis
In our study, genome-wide DNAm profiling in whole blood of twins was performed using RRBS, yielding 551,447 raw CpGs. RRBS analysis was performed on whole blood DNA by a Chinese biomarker technology company. Concisely, genomic DNA was digested with MspI enzyme to generate CpG-rich short fragments, which were then selected and bisulfite-converted. To obtain methylation data, the bisulfite-converted DNA fragments were used for sequencing, and the resulting raw data were preprocessed, mapped with Bismark [27], and smoothed using the R-package BiSeq [28]. We established coverage control at the 90th percentile and omitted CpGs displaying methylation β-values < 0.01 or those with more than 10 missing observations. After these quality control, a total of 248,840 CpGs remained for subsequent analyses. To facilitate statistical analysis, we converted the methylation β-value to M-value.
To mitigate the risk of false discoveries that could result from varying methylation profiles of different cell types in whole blood samples [29], we employed the ReFACTor method. For our study, we controlled for the influence of cell-type composition on DNAm by included the top five components identified by the method as variables [30] (Table S1).
Statistical analysis
Mediation analyses
The current study used the Causal Inference Test (CIT) to assess the potential mediating role of DNAm in the association between handgrip strength and cognitive function [31]. Each CpG had four models fitted separately, including the following: In Model 1, we examined the association between handgrip strength and cognitive function. To implement the generalized estimating equation (GEE), we consulted the R-package geepack and its corresponding geeglm function. Here, cognitive function served as the outcome, while handgrip strength was the predictor. We took into account variables such as sex, age, cell-type composition, and twin pairing; In Model 2: we focused on the association between handgrip strength and DNAm of each CpG through an EWAS. In this model, we used GEE, controlling for cognitive function. DNAm of each CpG was the outcome, and handgrip strength was the predictor. We again adjusted for sex, age, cell-type composition, twin pairing, and cognitive function. We explained intra-pair correlation by setting the ID=family_ID parameter in the model, and intra-cohort correlation was elucidated by setting the corstr = “exchangeable” parameter. The Manhattan plot was generated from the EWAS. To correct for multiple testing, we calculated false discovery rate (FDR) and defined FDR < 0.05 as genome-wide significance. For CpGs with FDR ≥ 0.05, we defined P < 1×10−6 as suggestive significance and 1 × 10−6 ≤ P < 1 × 10−5 as weaker-than-suggestive significance. The CpGs with P < 1 × 10−4 were reported as top CpGs of this EWAS.The CpGs that exhibited P values of association < 1 × 10−4 were chosen for further analysis; In Model 3: the association between the DNAm of each CpG and cognitive function was evaluated. This model employed GEE while controlling for handgrip strength. Adjustments were made for gender, age, cell-type composition, twin pairing, and handgrip strength. We selected CpGs with association P values < 0.05 as candidate mediators; In Model 4: we used the R-package mediation to analyze how the DNAm of each CpG mediated the association between handgrip strength and cognitive function [32]. Estimates and 95% confidence intervals (95% CIs) were determined after running 5000 simulations. The average causal mediation effect (ACME), average direct effect (ADE), total impact, and the absolute value of the ratio of mediated effects to direct effects were determined for each CpG. If the P value associated with the ACME for a specific CpG was < 0.05, it was considered that this CpG played a significant mediating role in the association between handgrip strength and cognitive function. Furthermore, for CpG mediators deemed significant, we conducted an assessment of the exposure-mediator interaction, with statistical significance set at P < 0.05. SPSS 22.0 and PROCESS v3.5 were used for parallel mediation analysis. Ultimately, we assessed the potential mediating role of handgrip strength on the association between the DNAm at each CpG and cognitive function.
Region-based analysis
The comb-p method was employed to identify differentially methylated regions (DMRs) associated with predictors for the CpGs (P < 0.05) discovered in Model 2 through EWAS [33,34,35]. DMRs with significant enrichment were identified using a Stouffer-Liptak-Kechris (slk) adjusted P value < 0.05.
Ontology enrichment analysis
We used the GREAT program to conduct an analysis of the functional ontology enrichments for CpGs from Model 2 that had association P values < 0.05, as well as the candidate CpG mediators that were found in Model 3 [36]. The detailed setup has been explained in previous articles [35, 37, 38]. The ontology enrichments that were deemed significant were evaluated based on a FDR of <0.05.
Results
Characteristics of participants
The fundamental characteristics of the enrolled individuals are shown in Table 1. The sample comprised 59 pairs of twins, with 33 pairs consisting of males. The participants had a median age of 52 years (95% range: 41–66), a median handgrip strength of 33.26 kg (SD: 11.59), and a mean cognitive function score of 19.65 (SD: 5.30). Handgrip strength demonstrated a significant intra-pair correlation (r = 0.860, P < 0.001), whereas the intra-pair correlation within cognitive function score was not deemed statistically significant (r = 0.252, P = 0.054). In addition,the substantial proportion of the clinical indicators demonstrated statistically significant correlations within twin pairs, suggesting the advantageous implications of using a co-twin design.
Association of handgrip strength and cognitive function
Handgrip strength was positively associated with cognitive function in twins (β = 0.194, P < 0.001) in Model 1.
Association of handgrip strength and DNAm while controlling for cognitive function
Based on the visual representation of the Manhattan plot (Fig. 1) and the data presented in Table S2, it was evident that there existed a significant association between handgrip strength and DNAm of 124 CpGs, reaching a statistical significance level of P < 1 × 10−4 in Model 2. There was an negative association between handgrip strength and the DNAm of 85 CpGs. The majority of these 85 CpGs were located at/near EBF3 (n = 8) (β = −0.02), WNK2 (n = 7) (β = −0.03), SNTG2 (n = 7) (β = −0.03), TYW1B (n = 5) (β = −0.24), CCDC144A (n = 4) (β = −0.18), NEUROG3 (n = 4) (β = −0.03), PLEKHA2 (n = 4) (β = −0.03), RXRA (n = 4) (β = −0.47), FOXA1/ TTC6 (n = 3) (β = −0.03), and FOXA2 (n = 3) (β = −0.03). The DNAm of 39 CpGs was positively associated with handgrip strength, with the majority of CpGs located at/near FBLN1 (n = 7) (β = 0.04), CELF2 (n = 4) (β = 0.07), GPR157 (n = 3) (β = 0.05), INPP5A (n = 3) (β = 0.03), KRBA1 (n = 3) (β = 0.04), and MFSD6 (n = 3) (β = 0.26).
Table 2 listed 15 DMRs that may be associated with handgrip strength. The pattern of differential methylation was depicted in Fig. 2. The association between handgrip strength and methylation levels differed for 3 DMRs (DMR-C, G, L) compared to the majority of DMRs (DMR-A, D, E-F, J-K, M-N), which exhibited hypermethylation with increasing handgrip strength (Fig. 2). However, the precise associations between 4 DMRs (DMR-B, H, I, O) and handgrip strength remained unclear. Notably, 7 DMRs falling into FBLN1, EBF3, WNK2, KRBA1, TIMP2, SNTG2, and NEUROG3 also covered the top CpGs listed in Table S2.
For the identified CpGs (P value < 0.05), numerous GREAT ontology enrichments potentially associated with handgrip strength were discovered. These enrichments included p53 pathway by glucose deprivation, ATP synthesis, genes related to the regulation of the actin cytoskeleton, and insulin-mediated glucose transport, etc (Fig. S1).
Association of DNAm with cognitive function while controlling for handgrip strength
In Model 3, there was a significant association (P < 0.05) between the DNAm at 13 CpGs and cognitive function (Table S3). These candidate CpG mediators mapped to KCNN3, KRBA1, ST8SIA5, FOXA2, ULK4, SNCB, ALDH1B1, CNTNAP2, and FOXA1, and were mainly involved in dopaminergic neuron differentiation, response to interleukin-6, cell differentiation in hindbrain, and FOXA family transcription factor networks, etc (Fig. S2).
Mediation analysis
In Model 4 (Table 3), we discovered that 3 CpGs mapped to KRBA1 and 1 CpG mapped to TRAK1 could mediate the association between handgrip strength and cognitive function (P value of ACME < 0.05). Nearly all the DNAm of these CpGs was with an ADE of 0.254 and an ACME of −0.050. This indicated that, after averaging the ADE across 4 CpGs and controlling for methylation at these CpGs, a positive association was observed between handgrip strength and cognitive function. In other words, for each 1 kg increase in handgrip strength, there was an associated increase of 0.254 points in cognitive function scores. Similarly, the ACME for these 4 CpGs indicated that the methylation at these CpGs mediated the association between handgrip strength and cognitive function. On average, each 1 kg increase in handgrip strength was associated with a potential decrease of 0.050 points in cognitive function scores, mediated by modifications in DNAm. The results of parallel mediation analysis showed that ADE of these 4 CpGs was 0.285 and ACME was −0.081. It was noteworthy that we observed handgrip strength exerted a positive direct effect on cognitive function, and the DNAm variation at these CpGs negatively mediated the effect of handgrip strength on cognitive function. In other words, the mediating role of DNAm at these CpGs attenuated the positive impact of handgrip strength on cognitive function. Nevertheless, overall, there still exists a significant positive correlation between handgrip strength and cognitive function. In addition, we explored whether handgrip strength mediates the association between the four CpGs mentioned above and cognitive function. However, we found no statistically significant results.
Discussion
Current research widely recognizes low handgrip strength as a risk factor for cognitive function decline. Using a sample of monozygotic twins, we identified four CpGs that mediate the association between handgrip strength and cognitive function. Importantly, our study emphasizes the significance of considering exposure and mediator interactions in epigenetic research.
In EWAS of handgrip strength, genes such as SNTG2, KLB, CDH11, and PANX2, where DMRs were located, could potentially exert substantial effects on handgrip strength. SNTG2 belonged to the syntrophin family and exhibited high expression in the musculoskeletal system [39]. So the suppression of SNTG2 expression might have had an impact on handgrip strength. The downregulation of the KLB gene was associated with skeletal muscle function [40]. CDH11 was known to play a pivotal role in inflammation-related conditions [41], including rheumatoid arthritis, thereby potentially influencing handgrip strength. The functional role of the remaining genes in relation to handgrip strength is currently unknown.
In the process of handgrip strength influencing cognitive function, we observed that the 4 CpG mediators identified were annotated near 2 important genes, namely KRBA1 and TRAK1. In addition, we utilized a causal inference methodology to demonstrate that handgrip strength can induce alterations in the methylation levels of KRBA1 and TRAK1. Three CpG mediators were annotated near KRBA1. John Alexander et al. found that KRBA1 possessed novel stop-gain mutations exclusively in individuals affected by familial early-onset dementia, as compared to those unaffected by the disease [42]. KRBA1 interacted with glycogen synthase kinase-3beta [42], which mediated neuroinflammation associated with Alzheimer’s disease [43]. Therefore, handgrip strength led to alterations in the methylation levels of KRBA1, which could subsequently have impacted cognitive function through an inflammatory pathway. One CpG mediator was annotated near TRAK1. It was predicted that TRAK1 enabled γ-aminobutyric acid receptor binding activity and myosin binding activity and was associated with severe neurodevelopmental disorders [44]. We hypothesized that the elevated methylation levels of TRAK1 induced by low handgrip strength affected γ-aminobutyric acid receptor binding activity, subsequently inhibiting acetylcholine synthesis, and ultimately influencing cognitive function.
We found that handgrip strength exerted a positive direct effect on cognitive function, and the DNAm variation negatively mediated the effect of handgrip strength on cognitive function. Several studies refer to the situation where the direction of the indirect effect is opposite to that of the direct effect as a “suppressing effect” [45,46,47,48]. In other words, the mediating effect of DNAm variation attenuated the positive impact of handgrip strength on cognitive function. Recently, several studies on DNAm variation have also demonstrated suppressing effects [49,50,51]. Given the complexity of DNAm in regulating gene expression, maintaining genomic stability, responding to environmental and lifestyle factors, and influencing the onset and progression of diseases, we consider this situation to be reasonable.
Our study has several strengths based on our findings. First and foremost, the utilization of a traits-discordant monozygotic twin design in our study has been recognized as a robust approach for detecting and understanding the epigenetic variations associated with complex diseases [22]. Secondly, to the best of our knowledge, this represents the first exploration of the mediating role of DNAm in the association between handgrip strength and cognitive function. Furthermore, considering the diverse genetic constitutions, environmental exposures, and multiple lifestyles across different ethnic populations worldwide, our findings will be particularly valuable in elucidating the underlying mechanisms of cognitive function decline in the Chinese population.
There are a number of limitations that should be acknowledged in our research. First, the limited sample size was attributed to the challenges encountered in recruiting and identifying eligible pairs of twins. Nevertheless, the use of the trait-discordant twin design in our study demonstrated superior statistical power in comparison to traditional cross-sectional or case-control designs. For handgrip strength and cognitive function, which exhibit a moderate level of heritability, their heritabilities were approximately 0.58 [52] and 0.44 [53], respectively. Consequently, the design of our study allowed for a reduction in the required sample size. The ratio of the minimum sample size between twin designs and conventional case-control designs was approximately 0.4, suggesting that the 118 participants in our study were equivalent to 295 participants in a typical case-control study. Second, although we adjusted for some confounding factors in the mediation analysis, the outcomes may still be influenced by residual confounding. And the possibility of a reverse causal association cannot be entirely ruled out. Third, although we have identified certain DNAm sites, our understanding of their functional implications remains incomplete. Further research is necessary to elucidate the underlying mechanisms involved. Finally, the rate of decline in handgrip strength and cognitive function were not only associated with age span but also with gender [54, 55]. Although we adjusted for age and gender in our study, we were still unable to eliminate the effects they exert. Therefore, future research with larger sample sizes is needed to explore potential gender differences.
In summary, we discovered specific DNAm sites that mediate the association between handgrip strength and cognitive function. Our findings provide important clues for further elucidating the underlying mechanisms of cognitive function decline.
Data availability
Data available on request from the authors.
References
Kabayama M, Mikami H, Kamide K. Factors associated with risk for assisted living among community-dwelling older Japanese. Arch Gerontol Geriatr. 2016;65:63–9.
Chang K-V, Hsu T-H, Wu W-T, Huang K-C, Han D-S. Association between sarcopenia and cognitive impairment: a systematic review and meta-analysis. J Am Med Dir Assoc. 2016;17:1164.e7–1164.e15.
Prince M, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M. World Alzheimer report 2015. The global impact of dementia: an analysis of prevalence, incidence, cost and trends: Alzheimer’s Disease International; 2015.
Gharbi-Meliani A, Dugravot A, Sabia S, Regy M, Fayosse A, Schnitzler A, et al. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study. Alzheimers Res Ther. 2021;13:5.
Kaivola K, Chia R, Ding J, Rasheed M, Fujita M, Menon V, et al. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias. Cell Genom. 2023;3:100316.
Sorrentino F, Fenoglio C, Sacchi L, Serpente M, Arighi A, Carandini T, et al. Klotho gene expression is decreased in peripheral blood mononuclear cells in patients with Alzheimer’s disease and frontotemporal dementia. J Alzheimers Dis. 2023;94:1225–31.
Xu Y, Sun Z, Jonaitis E, Deming Y, Lu Q, Johnson SC, et al. Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer’s disease and aging on preclinical cognitive function. Alzheimers Dement. 2024;20:1063–75.
Fritz NE, McCarthy CJ, Adamo DE. Handgrip strength as a means of monitoring progression of cognitive decline - A scoping review. Ageing Res Rev. 2017;35:112–23.
Liu J, Zhang T, Luo J, Chen S, Zhang D. Association between sleep duration and grip strength in U.S. Older Adults: An NHANES analysis (2011-2014). Int J Environ Res Public Health. 2023;20:3416.
Luo J, Yao W, Zhang T, Ge H, Zhang D. Exploring the bidirectional associations between handgrip strength and depression in middle and older Americans. J Psychosom Res. 2021;152:110678.
Radavelli-Bagatini S, Macpherson H, Scott D, Daly RM, Hodgson JM, Laws SM, et al. Impaired muscle function, including its decline, is related to greater long-term late-life dementia risk in older women. J Cachexia Sarcopenia Muscle. 2023;14:1508–19.
Duchowny KA, Ackley SF, Brenowitz WD, Wang J, Zimmerman SC, Caunca MR, et al. Associations between handgrip strength and dementia risk, cognition, and neuroimaging outcomes in the UK Biobank cohort study. JAMA Netw Open. 2022;5:e2218314.
Jia S, Zhao W, Ge M, Zhou L, Sun X, Zhao Y, et al. Association of handgrip strength weakness and asymmetry with incidence of motoric cognitive risk syndrome in the China Health and retirement longitudinal study. Neurology. 2023;100:e2342–e9.
McGrath R, Robinson-Lane SG, Cook S, Clark BC, Herrmann S, O’Connor ML, et al. HanDGRIP STRENGTH IS ASSOCIATED WITH POORER COGNITIVE FUNCTIONING IN AGing Americans. J Alzheimers Dis. 2019;70:1187–96.
Rijk JM, Roos PR, Deckx L, van den Akker M, Buntinx F. Prognostic value of handgrip strength in people aged 60 years and older: a systematic review and meta-analysis. Geriatr Gerontol Int. 2016;16:5–20.
Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology. 2002;59:371–8.
Raji MA, Kuo Y-F, Snih SA, Markides KS, Peek MK, Ottenbacher KJ. Cognitive status, muscle strength, and subsequent disability in older Mexican Americans. J Am Geriatr Soc. 2005;53:1462–8.
Alece Arantes Moreno I, Rodrigues de Oliveira D, Ribeiro Borçoi A, Fungaro Rissatti L, Vitorino Freitas F, Arantes LMRB, et al. Methylation of BDNF gene in association with episodic memory in women. Front Neurosci. 2023;17:1092406.
Di Francesco A, Arosio B, Falconi A, Micioni Di Bonaventura MV, Karimi M, Mari D, et al. Global changes in DNA methylation in Alzheimer’s disease peripheral blood mononuclear cells. Brain Behav Immun. 2015;45:139–44.
Peterson MD, Collins S, Meier HCS, Brahmsteadt A, Faul JD. Grip strength is inversely associated with DNA methylation age acceleration. J Cachexia Sarcopenia Muscle. 2023;14:108–15.
Li W, Christiansen L, Hjelmborg J, Baumbach J, Tan Q. On the power of epigenome-wide association studies using a disease-discordant twin design. Bioinformatics. 2018;34:4073–8.
Tan Q, Christiansen L, von Bornemann Hjelmborg J, Christensen K. Twin methodology in epigenetic studies. J Exp Biol. 2015;218:134–9.
Duan H, Ning F, Zhang D, Wang S, Zhang D, Tan Q, et al. The Qingdao twin registry: a status update. Twin Res Hum Genet. 2013;16:79–85.
Chen K-L, Xu Y, Chu A-Q, Ding D, Liang X-N, Nasreddine ZS, et al. Validation of the Chinese version of montreal cognitive assessment basic for screening mild cognitive impairment. J Am Geriatr Soc. 2016;64:e285–e90.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
Peavy GM, Jenkins CW, Little EA, Gigliotti C, Calcetas A, Edland SD, et al. Community memory screening as a strategy for recruiting older adults into Alzheimer’s disease research. Alzheimers Res Ther. 2020;12:78.
Krueger F, Andrews SR. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 2011;27:1571–2.
Hebestreit K, Dugas M, Klein H-U. Detection of significantly differentially methylated regions in targeted bisulfite sequencing data. Bioinformatics. 2013;29:1647–53.
Jaffe AE, Irizarry RA. Accounting for cellular heterogeneity is critical in epigenome-wide association studies. Genome Biol. 2014;15:R31.
Rahmani E, Zaitlen N, Baran Y, Eng C, Hu D, Galanter J, et al. Sparse PCA corrects for cell type heterogeneity in epigenome-wide association studies. Nat Methods. 2016;13:443–5.
Millstein J, Zhang B, Zhu J, Schadt EE. Disentangling molecular relationships with a causal inference test. BMC Genet. 2009;10:23.
Tingley D, Yamamoto T, Hirose K, Keele L, Imai K. Mediation: R package for causal mediation analysis. J Stat Softw. 2014;59:1–38.
Pedersen BS, Schwartz DA, Yang IV, Kechris KJ. Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values. Bioinformatics. 2012;28:2986–8.
Wang W, Li W, Jiang W, Lin H, Wu Y, Wen Y, et al. Genome-wide DNA methylation analysis of cognitive function in middle and old-aged Chinese monozygotic twins. J Psychiatr Res. 2021;136:571–80.
Wang W, Li W, Wu Y, Tian X, Duan H, Li S, et al. Genome-wide DNA methylation and gene expression analyses in monozygotic twins identify potential biomarkers of depression. Transl Psychiatry. 2021;11:416.
McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol. 2010;28:495–501.
Wang W, Li W, Duan H, Xu C, Tian X, Li S, et al. Mediation by DNA methylation on the association of BMI and serum uric acid in Chinese monozygotic twins. Gene. 2023;850:146957.
Wang W, Yao J, Li W, Wu Y, Duan H, Xu C, et al. Epigenome-wide association study in Chinese monozygotic twins identifies DNA methylation loci associated with blood pressure. Clin Epigenetics. 2023;15:38.
Moon JY, Choi SJ, Heo CH, Kim HM, Kim HS. α-Syntrophin stabilizes catalase to reduce endogenous reactive oxygen species levels during myoblast differentiation. FEBS J. 2017;284:2052–65.
Galmés S, Rupérez AI, Sánchez J, Moreno LA, Foraita R, Hebestreit A, et al. KLB and NOX4 expression levels as potential blood-based transcriptional biomarkers of physical activity in children. Sci Rep. 2023;13:5563.
Chen X, Xiang H, Yu S, Lu Y, Wu T. Research progress in the role and mechanism of Cadherin-11 in different diseases. J Cancer. 2021;12:1190–9.
Alexander J, Kalev O, Mehrabian S, Traykov L, Raycheva M, Kanakis D, et al. Familial early-onset dementia with complex neuropathologic phenotype and genomic background. Neurobiol Aging. 2016;42:199–204.
Samim Khan S, Janrao S, Srivastava S, Bala Singh S, Vora L, Kumar Khatri D. GSK-3β: An exuberating neuroinflammatory mediator in Parkinson’s disease. Biochem Pharmacol. 2023;210:115496.
Barel O, Malicdan MCV, Ben-Zeev B, Kandel J, Pri-Chen H, Stephen J, et al. Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy. Brain. 2017;140:568–81.
MacKinnon D. Introduction to Statistical Mediation Analysis (1st ed.). Routledge.
MacKinnon DP, Krull JL, Lockwood CM. Equivalence of the mediation, confounding and suppression effect. Prev Sci. 2000;1:173–81.
MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002;7:83–104.
Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods. 2002;7:422–45.
Wang Y, Tzeng J-Y, Huang Y, Maguire R, Hoyo C, Allen TK. Duration of exposure to epidural anesthesia at delivery, DNA methylation in umbilical cord blood and their association with offspring asthma in Non-Hispanic Black women. Environ Epigenet. 2023;9:dvac026.
Briollais L, Rustand D, Allard C, Wu Y, Xu J, Rajan SG, et al. DNA methylation mediates the association between breastfeeding and early-life growth trajectories. Clin Epigenetics. 2021;13:231.
Euclydes VLV, Gastaldi VD, Feltrin AS, Hoffman DJ, Gouveia G, Cogo H, et al. DNA methylation mediates a randomized controlled trial home-visiting intervention during pregnancy and the Bayley infant’s cognitive scores at 12 months of age. J Dev Orig Health Dis. 2022;13:556–65.
Luo J. Heritability and genome-wide association study of handgrip strength and lower limb motor function in twins [Master]: Qingdao University; 2023.
Xu C, Zhang D, Wu Y, Tian X, Pang Z, Li S, et al. A genome-wide association study of cognitive function in Chinese adult twins. Biogerontology. 2017;18:811–9.
Samson MM, Meeuwsen IB, Crowe A, Dessens JA, Duursma SA, Verhaar HJ. Relationships between physical performance measures, age, height and body weight in healthy adults. Age Ageing. 2000;29:235–42.
Suo J, Shen X, He J, Sun H, Shi Y, He R, et al. Exploring cognitive trajectories and their association with physical performance: evidence from the China Health and Retirement Longitudinal Study. Epidemiol Health. 2023;45:e2023064.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics
This study followed the Helsinki Declaration and was approved by the Regional Ethics Committee of the Institutional Review Committee of Qingdao CDC.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
10038_2024_1247_MOESM4_ESM.tif
The bar chart of top 50 GREAT ontology enrichments potentially related to handgrip strength for CpGs (P-value < 0.05) in Model 2 by using binomial test
10038_2024_1247_MOESM5_ESM.tif
The bar chart of GREAT ontology enrichments potentially related to cognitive function for candidate CpG mediators by using binomial test in Model 3
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, J., Wang, W., Luo, J. et al. Mediation role of DNA methylation in association between handgrip strength and cognitive function in monozygotic twins. J Hum Genet (2024). https://doi.org/10.1038/s10038-024-01247-4
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s10038-024-01247-4